SyntekaBio Inc (226330) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.169x

Based on the latest financial reports, SyntekaBio Inc (226330) has a cash flow conversion efficiency ratio of -0.169x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.01 Billion ≈ $-1.36 Million USD) by net assets (₩11.90 Billion ≈ $8.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is SyntekaBio Inc's balance sheet to measure how much of total assets are equity-financed.

SyntekaBio Inc - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how SyntekaBio Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SyntekaBio Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

SyntekaBio Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SyntekaBio Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Superhouse Limited NSE:SUPERHOUSE	0.110x
BIT Mining Limited NYSE:BTCM	-0.167x
B3 Consulting Group AB ST:B3	0.076x
Blender Financial Technologies Ltd TA:BLND	-0.053x
Comfort Gloves Bhd KLSE:2127	0.003x
Indara Insurance Public Company Limited BK:INSURE	0.071x
Able View Global Inc. Class B Ordinary Shares NASDAQ:ABLV	-0.121x
Orpheus Uranium Ltd AU:ORP	-0.119x

Annual Cash Flow Conversion Efficiency for SyntekaBio Inc (2017–2024)

The table below shows the annual cash flow conversion efficiency of SyntekaBio Inc from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 226330 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩24.94 Billion ≈ $16.90 Million	₩-10.51 Billion ≈ $-7.12 Million	-0.421x	-62.87%
2023-12-31	₩31.23 Billion ≈ $21.16 Million	₩-8.08 Billion ≈ $-5.47 Million	-0.259x	+4.38%
2022-12-31	₩31.46 Billion ≈ $21.32 Million	₩-8.51 Billion ≈ $-5.77 Million	-0.271x	-23.73%
2021-12-31	₩27.63 Billion ≈ $18.72 Million	₩-6.04 Billion ≈ $-4.09 Million	-0.219x	-94.57%
2020-12-31	₩41.54 Billion ≈ $28.15 Million	₩-4.67 Billion ≈ $-3.16 Million	-0.112x	-57.95%
2019-12-31	₩46.11 Billion ≈ $31.25 Million	₩-3.28 Billion ≈ $-2.22 Million	-0.071x	+95.06%
2018-12-31	₩1.64 Billion ≈ $1.11 Million	₩-2.37 Billion ≈ $-1.60 Million	-1.441x	-261.66%
2017-12-31	₩-2.79 Billion ≈ $-1.89 Million	₩-2.49 Billion ≈ $-1.69 Million	0.891x	--

About SyntekaBio Inc

KQ:226330 Korea Health Information Services

Market Cap

$18.90 Million

₩27.89 Billion KRW

Market Cap Rank

#25257 Global

#1839 in Korea

Share Price

₩1528.00

Change (1 day)

+6.70%

52-Week Range

₩1369.00 - ₩6260.00

All Time High

₩43250.00